Vident Advisory’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.57M | Buy |
33,624
+7,415
| +28% | +$787K | 0.04% | 349 |
|
|
2025
Q1 | $3.25M | Sell |
26,209
-3,053
| -10% | -$379K | 0.05% | 329 |
|
|
2024
Q4 | $3.6M | Buy |
29,262
+217
| +0.7% | +$26.7K | 0.06% | 280 |
|
|
2024
Q3 | $3.24M | Buy |
29,045
+26,917
| +1,265% | +$3M | 0.08% | 257 |
|
|
2024
Q2 | $227K | Sell |
2,128
-122,131
| -98% | -$13M | 0.01% | 1238 |
|
|
2024
Q1 | $15M | Buy |
124,259
+35,347
| +40% | +$4.26M | 0.31% | 101 |
|
|
2023
Q4 | $10.9M | Buy |
88,912
+86,702
| +3,923% | +$10.7M | 0.27% | 118 |
|
|
2023
Q3 | $286K | Buy |
+2,210
| New | +$286K | 0.01% | 933 |
|